510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K853279Substantially Equivalent

Coxsackie A2 Cf Antigen, A4, A10 & A16

Hillcrest Biologicals, Cypress CA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K853279 is the FDA 510(k) clearance record for COXSACKIE A2 CF ANTIGEN, A4, A10 & A16, a class I device, cleared for Hillcrest Biologicals on under FDA product code GNO (Antisera, Cf, Coxsackievirus A 1-24, B 1-6). FDA records list 33 510(k) clearances for Hillcrest Biologicals, from to . As of , FDA records show no recalls naming K853279.

Clearance record

Decision date
Received
(94 days to decision)
Product code
GNO Antisera, Cf, Coxsackievirus A 1-24, B 1-6
Regulation
21 CFR 866.3145
Device class
Class I
Review panel
Microbiology
Applicant
Hillcrest Biologicals 10703 Progress Way, Cypress CA
Third party review
No

Clearances, product code GNO

Trailing 12 months

FDA records hold no clearances under product code GNO in the trailing twelve months.

FDA records show no clearances under product code GNO in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code GNO, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260